Highlights AstraZeneca PLC

Equities

AZN

GB0009895292

Pharmaceuticals

Real-time Estimate Cboe Europe Other stock markets 20:16:02 17/04/2026 HKT			5-day change	1st Jan Change
14,866.00 ^GBX	+0.03%		-2.42%	+7.77%

04-17	AIM ImmunoTech Starts Late-Stage Trial of Ampligen in Pancreatic Cancer	MT
04-16	UK stocks close higher as energy sector gains tracking rise in oil prices	RE

Highlights

04-15	European shares flat as investors weigh corporate earnings; Middle East in focus	RE
04-10	Wall Street Gets a CPI Lifeline
04-09	Ideaya Biosciences, Inc. And Astrazeneca Plc Enter Clinical Collaboration Agreement	CI
04-08	Fda approves multiple generics of Farxiga	RE
04-07	Aurobindo Pharma Limited Receives USFDA Approval For Dapagliflozin And Metformin Hydrochloride Extended-Release Tablets	CI
04-07	Aurobindo Pharma receives USFDA Approval for Dapagliflozin Tablets, 5 mg and 10 mg	CI
04-07	Alembic Pharmaceuticals Limited Receives Usfda Final Approval for Dapagliflozin Tablets, 5 Mg and 10 Mg	CI
04-02	Harmony Biosciences Holdings, Inc. Announces Management Changes	CI
04-02	AstraZeneca's liver cancer therapy combo slows disease progression in late-stage trial	RE
04-02	Astrazeneca plc Announces Positive High-Level Results from the Emerald-3 Phase III Trial	CI
04-02	US Set to Impose 100% Tariffs on Some Drug Imports	MT
04-01	Health Care Up Amid Deal Activity -- Health Care Roundup	DJ
03-31	BofA Notes AstraZeneca's Mixed Efzimfotase Alfa Late-stage Data; Buy Reaffirmed	MT
03-31	AstraZeneca PLC Demonstrates Positive Results for Efzimfotase Alfa Phase III Program	CI
03-31	Astrazeneca plc Demonstrates Positive Results for Efzimfotase Alfa Phase III Program	CI
03-30	Eli Lilly Strikes AI Drug Discovery Deal With InSilico Worth Up to $2.75 Billion -- Update	DJ
03-30	Jacobio Pharmaceuticals Group Co., Ltd. Receives USD 100 Million Upfront Payment From Astrazeneca Under License And Cooperation Agreement For Pan-KRAS Inhibitor JAB-23E73	CI
03-28	Health Care Down as Traders Rotate to Other Defensive Areas -- Health Care Roundup	DJ
03-27	European Stocks Falling in Friday Trading as Investors Remain Jittery Over Middle East Conflict, Rising Oil Prices	MT
03-27	AstraZeneca Maintained at Buy as BofA Notes Positive Tozorakimab Late-stage Data	MT
03-27	AstraZeneca PLC Announces Tozorakimab Meets Primary Endpoints in OBERON and TITANIA Phase III Trials	CI
03-27	WINNERS & LOSERS: Metlen Energy takes hit from annual results delay	AN
03-27	Paris and European markets continue to retreat
03-27	AstraZeneca hails positive results in tozorakimab lung disease trials	AN
03-27	AstraZeneca drug reduces flare-ups of chronic lung disease in late-stage trials	RE